Skip to main content
Top
Published in: Digestive Diseases and Sciences 10/2006

01-10-2006 | Original Paper

Predictors of Cirrhosis in Hispanic Patients with Nonalcoholic Steatohepatitis

Authors: Waleed M. Alazmi, Arie Regev, Enrique G. Molina, Eugene R. Schiff

Published in: Digestive Diseases and Sciences | Issue 10/2006

Login to get access

Abstract

It is estimated that 43% of patients with nonalcoholic steatohepatitis (NASH) will progress to liver fibrosis or cirrhosis. Although NASH is more common in Hispanics, most studies have been conducted on Caucasians, and there is scarce information regarding ethnic differences in this disease. The aim of this study was to identify the independent predictors of cirrhosis in Hispanic patients with NASH. A retrospective case-control study was conducted on 80 patients with biopsy-proven NASH. Forty-two were Hispanic (study group) and 38 were Caucasians controlled for age and BMI (control group). Clinical, biochemical, and histologic features were analyzed for correlation with cirrhosis. There were no significant differences in demographic features between the two groups. In multivariate analysis, independent predictors of cirrhosis among Hispanic patients were age (OR, 1.07; 95% CI, 1.01–1.14) and AST/ALT ratio (OR, 10.56; 95% CI; 2.46–45.29), while independent predictors among non-Hispanic patients were age (OR, 1.085; 95% CI, 1.0–1.186), and diabetes mellitus (OR, 6.46; 95% CI, 1.19–35.07). In patients with NASH, predictors of cirrhosis varied according to ethnic background. Age was an independent predictor in both groups, however, AST/ALT ratio was found to be an independent predictor of cirrhosis only in Hispanic patients, and diabetes mellitus only in non-Hispanic patients.
Literature
1.
go back to reference Contos MJ, Sanyal AJ (2002) The clinicopathologic spectrum and management of nonalcoholic fatty liver disease. Adv Anat Pathol 9:37–51PubMedCrossRef Contos MJ, Sanyal AJ (2002) The clinicopathologic spectrum and management of nonalcoholic fatty liver disease. Adv Anat Pathol 9:37–51PubMedCrossRef
2.
go back to reference Youssef W, McCullough AJ (2002) Diabetes mellitus, obesity, and hepatic steatosis. Semin Gastrointest Dis 13:17–30PubMed Youssef W, McCullough AJ (2002) Diabetes mellitus, obesity, and hepatic steatosis. Semin Gastrointest Dis 13:17–30PubMed
4.
go back to reference Bellentani S, Tiribelli C, Saccoccio G, Sodde M, Fratti N, De Martin C (1994) Prevalence of chronic liver disease in the general population of northern Italy: the Dyonisos study. Hepatology 20:1442–1449PubMedCrossRef Bellentani S, Tiribelli C, Saccoccio G, Sodde M, Fratti N, De Martin C (1994) Prevalence of chronic liver disease in the general population of northern Italy: the Dyonisos study. Hepatology 20:1442–1449PubMedCrossRef
5.
go back to reference Weston SR, Leyden W, Murphy R, Bass NM, Bell BP, Manos MM, Terrault NA (2005) Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease. Hepatology 41(2):372–379PubMedCrossRef Weston SR, Leyden W, Murphy R, Bass NM, Bell BP, Manos MM, Terrault NA (2005) Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease. Hepatology 41(2):372–379PubMedCrossRef
6.
go back to reference Lee RG (1979) Non-alcoholic steatohepatitis: a study of 49 patients. Hum Pathol 20:594–598CrossRef Lee RG (1979) Non-alcoholic steatohepatitis: a study of 49 patients. Hum Pathol 20:594–598CrossRef
7.
go back to reference Powell EE, Cookesley EGE, Hanson R, et al. (1990) The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 11:74–80PubMed Powell EE, Cookesley EGE, Hanson R, et al. (1990) The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 11:74–80PubMed
8.
go back to reference Bacon BR, Farahvash MJ, Janney CG, et al. (1994) Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 107:1103–1109PubMed Bacon BR, Farahvash MJ, Janney CG, et al. (1994) Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 107:1103–1109PubMed
9.
go back to reference Abdelmalek M, Ludwig J, Lindor KD (1995) Two cases from the spectrum of non-alcoholic steatohepatitis. J Clin Gastroenterol 20:127–130PubMedCrossRef Abdelmalek M, Ludwig J, Lindor KD (1995) Two cases from the spectrum of non-alcoholic steatohepatitis. J Clin Gastroenterol 20:127–130PubMedCrossRef
10.
go back to reference Cadwell S, Oelsner D, Iezzoni J, Hespenheide E, Battle E, Driscoll C (1999) Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 29:664–669CrossRef Cadwell S, Oelsner D, Iezzoni J, Hespenheide E, Battle E, Driscoll C (1999) Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 29:664–669CrossRef
11.
go back to reference McCullough AJ (2002) Update on nonalcoholic fatty liver disease. J Clin Gastroenterol 34(3):255–262PubMedCrossRef McCullough AJ (2002) Update on nonalcoholic fatty liver disease. J Clin Gastroenterol 34(3):255–262PubMedCrossRef
12.
go back to reference Garcia-Monson C, Martin-Perez E, Iacono OL, Fernandez-Bermejo M, Majano PL, Apolinario A (2000) Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity. J Hepatol 33:716–724CrossRef Garcia-Monson C, Martin-Perez E, Iacono OL, Fernandez-Bermejo M, Majano PL, Apolinario A (2000) Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity. J Hepatol 33:716–724CrossRef
13.
go back to reference Dixon JB, Bhathal PS, O’Brien PE (2001) Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 121:91–100PubMedCrossRef Dixon JB, Bhathal PS, O’Brien PE (2001) Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 121:91–100PubMedCrossRef
14.
go back to reference Chitturi S, Weltman M, Farrell GC, McDonald D, Kench J, Liddle C (2002) HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity. Hepatology 36:142–149PubMedCrossRef Chitturi S, Weltman M, Farrell GC, McDonald D, Kench J, Liddle C (2002) HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity. Hepatology 36:142–149PubMedCrossRef
15.
go back to reference Harrison SA, Oliver DA, Torgerson S, Hayashi P, Neuschwander-Tetri B (2003) NASH: clinical assessment of 501 patients from two separate academic medical centers with validation of a clinical scoring system for advanced hepatic fibrosis. Hepatology 34:511CrossRef Harrison SA, Oliver DA, Torgerson S, Hayashi P, Neuschwander-Tetri B (2003) NASH: clinical assessment of 501 patients from two separate academic medical centers with validation of a clinical scoring system for advanced hepatic fibrosis. Hepatology 34:511CrossRef
16.
go back to reference Angulo P, Keach J, Batts K, Lindor K (1999) Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 30:1356–1362PubMedCrossRef Angulo P, Keach J, Batts K, Lindor K (1999) Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 30:1356–1362PubMedCrossRef
17.
go back to reference Marceau P, Biron S, Hould F, Marceau S, Biron S (1999) Liver pathology and metabolic syndrome X in severe obesity. J Clin Endocrinol Metab 84:1513–1517PubMedCrossRef Marceau P, Biron S, Hould F, Marceau S, Biron S (1999) Liver pathology and metabolic syndrome X in severe obesity. J Clin Endocrinol Metab 84:1513–1517PubMedCrossRef
18.
go back to reference Ratziu V, Giral P, Charlotte F, Bruckert E, Thibault V, Theodorou I (2000) Liver fibrosis in overweight patients. Gastroenterology 118:1117–1123PubMedCrossRef Ratziu V, Giral P, Charlotte F, Bruckert E, Thibault V, Theodorou I (2000) Liver fibrosis in overweight patients. Gastroenterology 118:1117–1123PubMedCrossRef
19.
go back to reference Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20(7):1183–1197 Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20(7):1183–1197
20.
go back to reference National Cholesterol Education Program (1994) Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation 89(3):1333–1445 National Cholesterol Education Program (1994) Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation 89(3):1333–1445
21.
go back to reference Brunt EM, Janney CG, Di Bisceglie AM, Neuchwander-Tetri BA, Bacon BR (1999) Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94:2467–2474PubMedCrossRef Brunt EM, Janney CG, Di Bisceglie AM, Neuchwander-Tetri BA, Bacon BR (1999) Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94:2467–2474PubMedCrossRef
23.
go back to reference Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ (1999) Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116:1413–1419PubMedCrossRef Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ (1999) Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116:1413–1419PubMedCrossRef
24.
go back to reference Nonomura A, Mizukami Y, Unoura M, Kobayashi K, Takeda Y, Takeda R (1992) Clinicopathologic study of alcohol-like liver disease in non-alcoholics; non-alcoholic steatohepatitis and fibrosis. Gastroenterol Jpn 27:521–528PubMed Nonomura A, Mizukami Y, Unoura M, Kobayashi K, Takeda Y, Takeda R (1992) Clinicopathologic study of alcohol-like liver disease in non-alcoholics; non-alcoholic steatohepatitis and fibrosis. Gastroenterol Jpn 27:521–528PubMed
25.
go back to reference el Hassan AY, Ibrahim EM, al Mulhim FA, Nabhan AA, Chammas MY (1992) Fatty infiltration of the liver: analysis of prevalence, radiological and clinical features and influence on patient management. Br J Radiol 65:774–778PubMedCrossRef el Hassan AY, Ibrahim EM, al Mulhim FA, Nabhan AA, Chammas MY (1992) Fatty infiltration of the liver: analysis of prevalence, radiological and clinical features and influence on patient management. Br J Radiol 65:774–778PubMedCrossRef
26.
go back to reference Clark JM, Diehl AM (2003) Nonalcoholic fatty liver disease: an under-recognized cause of cryptogenic cirrhosis. JAMA 289:3000–3004PubMedCrossRef Clark JM, Diehl AM (2003) Nonalcoholic fatty liver disease: an under-recognized cause of cryptogenic cirrhosis. JAMA 289:3000–3004PubMedCrossRef
27.
go back to reference Charlton M (2004) Nonalcoholic fatty liver disease: a review of current understanding and future impact. Clin Gastroenterol Hepatol 2(12):1048–1058PubMedCrossRef Charlton M (2004) Nonalcoholic fatty liver disease: a review of current understanding and future impact. Clin Gastroenterol Hepatol 2(12):1048–1058PubMedCrossRef
28.
go back to reference Wanless IR, Lentz JS (1990) Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 12:1106–1110PubMed Wanless IR, Lentz JS (1990) Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 12:1106–1110PubMed
29.
go back to reference Wang J, Thornton JC, Burastero S, et al. (1996) Comparisons for body mass index and body fat percent among Puerto Ricans, blacks, whites and Asians living in the New York City area. Obes Res 4:377–384PubMed Wang J, Thornton JC, Burastero S, et al. (1996) Comparisons for body mass index and body fat percent among Puerto Ricans, blacks, whites and Asians living in the New York City area. Obes Res 4:377–384PubMed
30.
go back to reference Kral JG, Schaffner F, Pierson RN Jr, Wang J (1993) Body fat topography as an independent predictor of fatty liver. Metabolism 42:548–551PubMedCrossRef Kral JG, Schaffner F, Pierson RN Jr, Wang J (1993) Body fat topography as an independent predictor of fatty liver. Metabolism 42:548–551PubMedCrossRef
31.
go back to reference Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL (1998) Overweight and obesity in the United States: prevalence and trends, 1960–1994. Int J Obes Relat Metab Disord 22:39–47PubMedCrossRef Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL (1998) Overweight and obesity in the United States: prevalence and trends, 1960–1994. Int J Obes Relat Metab Disord 22:39–47PubMedCrossRef
32.
go back to reference Casas YG, Schiller BC, DeSouza CA, Seals DR (2001) Total and regional body composition across age in healthy Hispanic and white women of similar socioeconomic status. Am J Clin Nutr 73:13–18PubMed Casas YG, Schiller BC, DeSouza CA, Seals DR (2001) Total and regional body composition across age in healthy Hispanic and white women of similar socioeconomic status. Am J Clin Nutr 73:13–18PubMed
33.
go back to reference Struben VMD, Hespenheide EE, Caldwell SH (2000) Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds. Am J Med 108:9–13PubMedCrossRef Struben VMD, Hespenheide EE, Caldwell SH (2000) Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds. Am J Med 108:9–13PubMedCrossRef
Metadata
Title
Predictors of Cirrhosis in Hispanic Patients with Nonalcoholic Steatohepatitis
Authors
Waleed M. Alazmi
Arie Regev
Enrique G. Molina
Eugene R. Schiff
Publication date
01-10-2006
Published in
Digestive Diseases and Sciences / Issue 10/2006
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-005-9065-1

Other articles of this Issue 10/2006

Digestive Diseases and Sciences 10/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.